A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL

Human Molecular Genetics

Volumn 20, Issue 24, 2011, Pages 4903-4915

  Han, Bo Wei ^a   Feng, Dan Dan ^a   Li, Zhi Gang ^b   Luo, Xue Qun ^c   Zhang, Hua ^a   Li, Xiao Juan ^a   Zhang, Xing Ju ^a   Zheng, Ling Ling ^a   Zeng, Cheng Wu ^a   Lin, Kang Yu ^a   Zhang, Peng ^e   Xu, Ling ^d   Chen, Yue Qin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; GLUCOCORTICOID; MICRORNA; MICRORNA 708; MICRORNA223; MICRORNA27A; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE FUNCTION; GENOME; HUMAN; HUMAN CELL; INFANT; MALE; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE; UPREGULATION;

ADOLESCENT; BASE SEQUENCE; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REGULATORY NETWORKS; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; NEOPLASTIC STEM CELLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 81855183744     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr428     Document Type: Article

References (51)

1. Pui, C.H., Campana, D. and Evans, W.E. (2001) Childhood acute lymphoblastic leukaemia-current status and future perspectives. Lancet Oncol., 2, 597-607.
2. Gaynon, P.S. (2005) Childhood acute lymphoblastic leukaemia and relapse. Br. J. Haematol., 131, 579-587.
3. Borowitz, M.J., Pullen, D.J., Shuster, J.J., Viswanatha, D., Montgomery, K., Willman, C.L. and Camitta, B. (2003) Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. Leukemia, 17, 1566-1572.
4. Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. et al. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
5. Coustan-Smith, E., Sancho, J., Hancock, M.L., Boyett, J.M., Behm, F.G., Raimondi, S.C., Sandlund, J.T., Rivera, G.K., Rubnitz, J.E., Ribeiro, R.C. et al. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 96, 2691-2696.
6. Cave, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B. and Vilmer, E. (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. N. Engl. J. Med., 339, 591-598.
7. Choi, S., Henderson, M.J., Kwan, E., Beesley, A.H., Sutton, R., Bahar, A.Y., Giles, J., Venn, N.C., Pozza, L.D., Baker, D.L. et al. (2007) Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood, 110, 632-639.
8. Zuna, J., Ford, A.M., Peham, M., Patel, N., Saha, V., Eckert, C., Kochling, J., Panzer-Grumayer, R., Trka, J. and Greaves, M. (2004) TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clin. Cancer Res., 10, 5355-5360.
9. Beesley, A.H., Cummings, A.J., Freitas, J.R., Hoffmann, K., Firth, M.J., Ford, J., de Klerk, N.H. and Kees, U.R. (2005) The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br. J. Haematol., 131, 447-456.
10. Bhojwani, D., Kang, H., Moskowitz, N.P., Min, D.J., Lee, H., Potter, J.W., Davidson, G., Willman, C.L., Borowitz, M.J., Belitskaya-Levy, I. et al. (2006) Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood, 108, 711-717.
11. Staal, F.J., de Ridder, D., Szczepanski, T., Schonewille, T., van der Linden, E.C., van Wering, E.R., van der Velden, V.H. and van Dongen, J.J. (2010) Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype. Leukemia, 24, 491-499.
12. Mattick, J.S. and Makunin, I.V. (2005) Small regulatory RNAs in mammals. Hum. Mol. Genet., 14(Suppl. 1), R121-R132.
13. Chen, C.Z., Li, L., Lodish, H.F. and Bartel, D.P. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-86.
14. Blenkiron, C. and Miska, E.A. (2007) miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet., 16(Suppl. 1), R106-R113.
15. Marcucci, G., Mrozek, K., Radmacher, M.D., Garzon, R. and Bloomfield, C.D. (2010) The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood, 117, 1121-1129.
16. Fulci, V., Colombo, T., Chiaretti, S., Messina, M., Citarella, F., Tavolaro, S., Guarini, A., Foa, R. and Macino, G. (2009) Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer, 48, 1069-1082.
17. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P., Wang, Y., Yan, M., Qian, Z. et al. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl Acad. Sci. USA, 105, 15535-15540.
18. Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M.B., Wang, Y., Qian, Z., Jin, J., Zhang, Y. et al. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl Acad. Sci. USA, 104, 19971-19976.
19. Rainer, J., Ploner, C., Jesacher, S., Ploner, A., Eduardoff, M., Mansha, M., Wasim, M., Panzer-Grumayer, R., Trajanoski, Z., Niederegger, H. et al. (2009) Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia, 23, 746-752.
20. Starczynowski, D.T., Morin, R., McPherson, A., Lam, J., Chari, R., Wegrzyn, J., Kuchenbauer, F., Hirst, M., Tohyama, K., Humphries, R.K. et al. (2010) Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood, 117, 595-607.
21. Feng, D.D., Zhang, H., Zhang, P., Zheng, Y.S., Zhang, X.J., Han, B.W., Luo, X.Q., Xu, L., Zhou, H., Qu, L.H. et al. (2010) Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukemia. J. Cell Mol. Med. [Epub ahead of print].
22. Kotani, A., Ha, D., Hsieh, J., Rao, P.K., Schotte, D., den Boer, M.L., Armstrong, S.A. and Lodish, H.F. (2009) miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood, 114, 4169-4178.
23. Kotani, A., Ha, D., Schotte, D., den Boer, M.L., Armstrong, S.A. and Lodish, H.F. (2010) A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells. Cell Cycle, 9, 1037-1042.
24. Lall, S., Grun, D., Krek, A., Chen, K., Wang, Y.L., Dewey, C.N., Sood, P., Colombo, T., Bray, N., Macmenamin, P. et al. (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr. Biol., 16, 460-471.
25. Maere, S., Heymans, K. and Kuiper, M. (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 21, 3448-3449.
26. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504.
27. Raaphorst, F.M. (2003) Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol., 24, 522-524.
28. Park, I.K., Qian, D., Kiel, M., Becker, M.W., Pihalja, M., Weissman, I.L., Morrison, S.J. and Clarke, M.F. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 423, 302-305.
29. Pulikkan, J.A., Dengler, V., Peramangalam, P.S., Peer Zada, A.A., Muller-Tidow, C., Bohlander, S.K., Tenen, D.G. and Behre, G. (2010) Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood, 115, 1768-1778.
30. Hui, R.C., Gomes, A.R., Constantinidou, D., Costa, J.R., Karadedou, C.T., Fernandez de Mattos, S., Wymann, M.P., Brosens, J.J., Schulze, A. and Lam, E.W. (2008) The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression. Mol. Cell Biol., 28, 5886-5898.
31. Miyamoto, K., Araki, K.Y., Naka, K., Arai, F., Takubo, K., Yamazaki, S., Matsuoka, S., Miyamoto, T., Ito, K., Ohmura, M. et al. (2007) Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell, 1, 101-112.
32. Tothova, Z., Kollipara, R., Huntly, B.J., Lee, B.H., Castrillon, D.H., Cullen, D.E., McDowell, E.P., Lazo-Kallanian, S., Williams, I.R., Sears, C. et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 128, 325-339.
33. Inaba, H. and Pui, C.H. (2010) Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol., 11, 1096-1106.
34. Jiang, N., Koh, G.S., Lim, J.Y., Kham, S.K., Ariffin, H., Chew, F.T. and Yeoh, A.E. (2011) BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Exp. Hematol., 39, 321-329.
35. Laios, A., O'Toole, S., Flavin, R., Martin, C., Kelly, L., Ring, M., Finn, S.P., Barrett, C., Loda, M., Gleeson, N. et al. (2008) Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer, 7, 35.
36. Chiaretti, S., Messina, M., Tavolaro, S., Zardo, G., Elia, L., Vitale, A., Fatica, A., Gorello, P., Piciocchi, A., Scappucci, G. et al. (2010) Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223. Haematologica, 95, 1114-1121.
37. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Saussoy, P., Van Den Neste, E., Michaux, L., Heimann, P., Martiat, P., Bron, D. and Lagneaux, L. (2009) microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood, 113, 5237-5245.
38. Mertens-Talcott, S.U., Chintharlapalli, S., Li, X. and Safe, S. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res., 67, 11001-11011.
39. Chintharlapalli, S., Papineni, S., Abdelrahim, M., Abudayyeh, A., Jutooru, I., Chadalapaka, G., Wu, F., Mertens-Talcott, S., Vanderlaag, K., Cho, S.D. et al. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int. J. Cancer, 125, 1965-1974.
40. Lessard, J. and Sauvageau, G. (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423, 255-260.
41. Naka, K., Hoshii, T., Muraguchi, T., Tadokoro, Y., Ooshio, T., Kondo, Y., Nakao, S., Motoyama, N. and Hirao, A. (2010) TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature, 463, 676-680.
42. Myatt, S.S. and Lam, E.W. (2007) The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer, 7, 847-859.
43. Waanders, E., van der Velden, V.H., van der Schoot, C.E., van Leeuwen, F.N., van Reijmersdal, S.V., de Haas, V., Veerman, A.J., van Kessel, A.G., Hoogerbrugge, P.M., Kuiper, R.P. et al. (2011) Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia, 25, 254-258.
44. Wu, S., Fischer, L., Gökbuget, N., Schwartz, S., Burmeister, T., Notter, M., Hoelzer, D., Fuchs, H., Blau, I.W., Hofmann, W.K. et al. (2010) Expression of interleukin 15 in primary adult acute lymphoblastic leukemia. Cancer, 116, 387-392.
45. Jiao, Y., Cui, L., Gao, C., Li, W., Zhao, X., Liu, S., Wu, M., Deng, G. and Li, Z. (2011) CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia. Leuk. Res. [Epub ahead of print].
46. Kang, H., Chen, I.M., Wilson, C.S., Bedrick, E.J., Harvey, R.C., Atlas, S.R., Devidas, M., Mullighan, C.G., Wang, X., Murphy, M. et al. (2010) Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood, 115, 1394-1405.
47. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
48. Castillo-Davis, C.I. and Hartl, D.L. (2003) GeneMerge-post-genomic analysis, data mining, and hypothesis testing. Bioinformatics, 19, 891-892.
49. Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M. et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques, 34, 374-378.
50. Zhang, L., Chia, J.M., Kumari, S., Stein, J.C., Liu, Z., Narechania, A., Maher, C.A., Guill, K., McMullen, M.D. and Ware, D. (2009) A genome-wide characterization of microRNA genes in maize. PLoS Genet., 5, e1000716.
51. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. and Golani, I. (2001) Controlling the false discovery rate in behavior genetics research. Behav. Brain Res., 125, 279-284.